Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-068925
Filing Date
2026-02-25
Accepted
2026-02-25 09:31:15
Documents
126
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alks-20251231.htm   iXBRL 10-K 5881679
2 EX-4.1 alks-ex4_1.htm EX-4.1 114041
3 EX-10.24 alks-ex10_24.htm EX-10.24 145228
4 EX-19.1 alks-ex19_1.htm EX-19.1 86067
5 EX-21.1 alks-ex21_1.htm EX-21.1 35129
6 EX-23.1 alks-ex23_1.htm EX-23.1 4341
7 EX-31.1 alks-ex31_1.htm EX-31.1 20226
8 EX-31.2 alks-ex31_2.htm EX-31.2 20139
9 EX-32.1 alks-ex32_1.htm EX-32.1 25172
10 GRAPHIC img20843373_0.jpg GRAPHIC 90492
11 GRAPHIC img20843373_1.jpg GRAPHIC 134869
12 GRAPHIC img20843373_2.gif GRAPHIC 46223
13 GRAPHIC img20843373_3.gif GRAPHIC 24075
14 GRAPHIC img20843373_4.gif GRAPHIC 10761
15 GRAPHIC img20843373_5.jpg GRAPHIC 239346
  Complete submission text file 0001193125-26-068925.txt   24990485

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20251231.xsd EX-101.SCH 2558652
129 EXTRACTED XBRL INSTANCE DOCUMENT alks-20251231_htm.xml XML 5391466
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35299 | Film No.: 26674658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)